Emergence of a definitive link between Epstein–Barr virus (EBV) and multiple sclerosis has
provided an impetus to develop immune‐based therapies to target EBV‐infected B cells …

Compelling evidence indicates that Epstein Barr virus (EBV) infection is a prerequisite for
multiple sclerosis (MS). The disease may arise from a complex interplay between latent EBV …

There is increasing evidence suggesting that Epstein-Barr virus infection is a causative
factor of multiple sclerosis (MS). Epstein-Barr virus (EBV) is a human herpesvirus, Human …

Low serum levels of 25-hydroxyvitamin D [25 (OH) D] and low sunlight exposure are known
risk factors for the development of multiple sclerosis. Add-on vitamin D supplementation …

Multiple sclerosis (MS) is a chronic disease affecting the brain and the spinal cord. It is a
chronic inflammatory demyelinating disease of the central nervous system. It is the leading …

The effects of environmental factors and epigenetics on health and disease development
are complex and interconnected. Environmental factors encompass external influences like …

Vaccine‐associated multiple sclerosis (MS) is rare, with insufficient evidence from case
reports. Given the scarcity of large‐scale data investigating the association between vaccine …

Since the first model of experimental autoimmune encephalomyelitis (EAE) was introduced
almost a century ago, there has been an ongoing scientific debate about the risks and …

Background The Greater Hobart region (42.5° S) of Tasmania has consistently had the
highest recorded prevalence and incidence rates of multiple sclerosis (MS) in Australia. We …

Limited studies have been conducted to identify and validate multiple sclerosis (MS) genetic
loci associated with disability progression. We aimed to identify MS genetic loci associated …